University of Missouri-Kansas City School of Medicine
Cardiovascular Disease fellowship · Kansas City, MO · Program website
Some matches pending. 6 people are awaiting a decision between possible publication profiles, so these numbers may change.
Trainees here publish less than most: 36% have published during training (9th of 9 cardiovascular disease fellowships with complete rosters), at 1.9 papers per trainee-year (4th), and they're first author on 35% of their papers. How trainees publish ↓
- 4
- Faculty
- 14
- Trainees
- 74
- Papers
- 36%
- Trainees published
- 1.89
- Papers / trainee-year
- 35%
- First author
Papers
By this program's faculty and trainees since 2022, 74 in all · 37 with a trainee author. Updated 2026-11-07.
- Association between family member bystander CPR and survival for out-of-hospital cardiac arrestManvita Tatavarthy et al. · Resuscitation Plus · 2026 · PubMed
- Trends in Guideline Directed Medical Therapy Use in Heart Failure With a Mildly Reduced Ejection FractionAndrew A. Girard et al. · JACC Heart Failure · 2026 · PubMed
- Association Between Maximum Temperature 24 Hours After Resuscitation and Survival for In‐Hospital Cardiac ArrestOmar Cantú-Martínez et al. · Journal of the American Heart Association · 2026 · PubMed
- Assessing the Prognostic Value of Serial Seattle Angina Questionnaire Scores in Chronic Coronary DiseaseEvan L. O’Keefe et al. · Circulation Population Health and Outcomes · 2026 · PubMed
- Refining the Role of Beta-Blockers in Cardiovascular MedicineBrett Wesley Sperry et al. · Journal of the American College of Cardiology · 2026 · PubMed
- Variability in Cardiac Stress Test Interpretation: Agreement Between Enrollment Sites and Core Laboratories in the Global ISCHEMIA TrialEvan L. O’Keefe et al. · Circulation Population Health and Outcomes · 2026 · PubMed
- Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.Areeba Moiz et al. · PubMed Central · 2026 · PubMed
- Time to Bystander Cardiopulmonary Resuscitation and Survival Outcomes in Pediatric Out-of-Hospital Cardiac Arrests in the United StatesMohammad Abdel Jawad et al. · Circulation Population Health and Outcomes · 2026 · PubMed
- Are Plasma Omega-3 Levels and Fish Oil Use Associated with Risk for Atrial Fibrillation? A UK Biobank AnalysisWilliam Harris et al. · Journal of clinical lipidology · 2026
- Lipid Lowering Therapy Optimization through the Primary Care Assist ProgramManvita Tatavarthy et al. · Journal of clinical lipidology · 2026
How trainees publishauthor positions, faculty co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 5 of 14 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Taiyeb Khumri, MD | Heart Failure Treatment and Management; CAR-T cell therapy research | 16 | 19 | 0 | 4 | 0.88 |
| Matthew Deedy, MD | Pulmonary and Respiratory Medicine | 2 | 0 | 0 | 0 | — |
| Chris DeZorzi, MD (unresolved) | — | — | 0 | 0 | 0 | — |
| Jon Enriquez, MD (unresolved) | — | — | 0 | 0 | 0 | — |
14 trainees are counted above but never listed by name.
About University of Missouri–Kansas Cityinstitution-wide cardiovascular disease research
Cardiovascular Disease publications from University of Missouri–Kansas City and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Cardiovascular Disease research topics at University of Missouri–Kansas City
Papers in the window; each links to the list on OpenAlex.
- Heart Failure Treatment and Management 258
- Cardiac Valve Diseases and Treatments 115
- Coronary Interventions and Diagnostics 82
- Congenital Heart Disease Studies 65
- Atrial Fibrillation Management and Outcomes 62
- Cardiomyopathy and Myosin Studies 54
- Mechanical Circulatory Support Devices 37
- Cardiac pacing and defibrillation studies 26
Most cited at University of Missouri–Kansas City since 2024
All cardiovascular disease papers there on OpenAlex
- Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 DiabetesMikhail Kosiborod et al. · New England Journal of Medicine · 2024 · PubMed · cited 792
- Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trialsJaved Butler et al. · The Lancet · 2024 · PubMed · cited 396
- Aficamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMartin S. Maron et al. · New England Journal of Medicine · 2024 · PubMed · cited 345
- Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trialsMikhail Kosiborod et al. · The Lancet · 2024 · PubMed · cited 323
- Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trialJohn Eric Deanfield et al. · The Lancet · 2024 · PubMed · cited 302
- Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent RestenosisRobert W. Yeh et al. · JAMA · 2024 · PubMed · cited 168
- Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart FailureScott David Solomon et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 154
- Inflammation in Obesity-Related HFpEFSubodh Verma et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 108
- Semaglutide and NT-proBNP in Obesity-Related HFpEFMark Colquhoun Petrie et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 99
- Left Atrial Appendage Closure or Anticoagulation for Atrial FibrillationShephal K. Doshi et al. · New England Journal of Medicine · 2026 · PubMed · cited 97